gainzlabuk.com
No products in the cart.
Return To Shopgainzlabuk.com
No products in the cart.
Return To ShopAntiflu 75 mg, manufactured by Cipla, is an antiviral medication primarily utilized for the treatment and prevention of influenza virus infections. This medication is aimed at alleviating the symptoms of influenza and reducing the duration of the illness when taken within the first 48 hours of symptom onset. Antiflu works by inhibiting the neuraminidase enzyme, which is crucial for the viral replication process. Its active ingredient is Oseltamivir Phosphate, a prodrug that is metabolized in the body to its active form, Oseltamivir.
The purpose of Antiflu is not only to treat the flu but also to serve as a prophylactic measure for individuals at high risk of developing influenza, particularly during flu outbreaks. It represents a vital component in managing flu-related health impacts, thereby promoting public health, especially in vulnerable populations.
Upon ingestion, Antiflu 75 mg is rapidly absorbed in the gastrointestinal tract and then metabolized into its active component, Oseltamivir carboxylate. This serum peak concentration occurs within 2 to 4 hours after administration, leading to the rapid suppression of the influenza virus. Oseltamivir carboxylate acts by competitively inhibiting the neuraminidase enzyme found on the virus’s surface. This inhibition prevents the release of newly replicated viral particles from infected cells, ultimately reducing the spread of the virus throughout the respiratory tract.
From a metabolic perspective, the effective inhibition of the influenza virus can lead to increased stamina and improved overall performance in those affected by influenza. By shortening the flu’s duration, individuals can return to their normal activities more swiftly, thereby minimizing disruption in daily routines and enhancing productivity.
The use of Antiflu 75 mg has several beneficial effects, particularly for individuals engaged in fitness activities or competitive sports.
These benefits make Antiflu a crucial ally for athletes during flu seasons when influenza can disrupt training and performance.
Antiflu 75 mg is typically prescribed in a dosage regimen that depends on factors like age, weight, and the severity of the flu.
Precise adherence to the dosage schedule is critical not only for effectiveness but also to minimize the development of antiviral resistance.
Like all medications, Antiflu 75 mg may cause side effects, although not everyone experiences them. Common side effects include nausea, vomiting, and abdominal pain. Less frequently reported effects involve headaches, dizziness, and in rare cases, neuropsychiatric events such as confusion or abnormal behavior, particularly in pediatric patients.
Proper use of Antiflu is vital in minimizing these side effects. Taking the medication with food can help reduce gastrointestinal upset. If users experience severe side effects or any unusual symptoms, it is paramount to seek medical attention immediately.
Monitoring during the use of Antiflu 75 mg is essential for ensuring safety and efficacy.
Monitoring ensures that the benefits of the medication outweigh any risks, especially in sensitive populations.
Purchasing Antiflu 75 mg Cipla in the United Kingdom can be done through various pharmacies; however, buying online from a reputable source is often more convenient.
Choosing our online store ensures not only quality but also a seamless purchasing experience, making it the preferred option for acquiring Antiflu 75 mg Cipla efficiently and reliably.
| Water Retention | None |
|---|---|
| Hepatotoxicity | Low risk |
| Lab Test | Not typically required for monitoring |
| Strength | 75mg |
| Also known as | Tamiflu |
| Blood pressure | No significant effects |
| Trade name | Tamiflu |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (3R,4R,5S)-4-acetylamino-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid, ethyl ester, phosphate (1:1) |
| Formula | C16H28N2O4 В· H3PO4 |
| Substance class | Antiviral |
| Main action | Neuraminidase inhibitor |
| Half-life | 6-10 hours |
| Dosage (medical) | 75 mg twice daily for 5 days |
| Dosage (sports) | Not applicable |
| Effects | Reduces severity and duration of influenza symptoms |
| Side effects | Nausea, vomiting, headache, and rare cases of severe skin reactions and neuropsychiatric events |
| Use in sports | Not typically used in sports |
| Manufacturer | Cipla Ltd. |
| Packing | 10 caps/blister |
€130.00
Reviews
There are no reviews yet.